Cargando…
Peptides-based therapeutics: Emerging potential therapeutic agents for COVID-19
SARS-CoV-2 is a positive-sense RNA virus and it is the causative agent of the global COVID-19 outbreak. COVID-19 is similar to the previous outbreaks for instance SARS in 2002-2003 and MERS in 2012. As the peptides have many advantages, peptide-based therapeutics might be one of the possible ways in...
Autores principales: | Shah, Jagat Narayan, Guo, Guang-Qin, Krishnan, Anand, Ramesh, Muthusamy, Katari, Naresh Kumar, Shahbaaz, Mohd, Abdellattif, Magda H., Singh, Sachin Kumar, Dua, Kamal |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Société française de pharmacologie et de thérapeutique. Published by Elsevier Masson SAS.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8498005/ https://www.ncbi.nlm.nih.gov/pubmed/34689960 http://dx.doi.org/10.1016/j.therap.2021.09.007 |
Ejemplares similares
-
A novel nano therapeutic using convalescent plasma derived exosomal (CP(Exo)) for COVID-19: A combined hyperactive immune modulation and diagnostics
por: Anand, Krishnan, et al.
Publicado: (2021) -
Current Perspectives in the Discovery of Newer Medications Against the Outbreak of COVID-19
por: Ramesh, M., et al.
Publicado: (2021) -
Natural products as novel anti-obesity agents: insights into mechanisms of action and potential for therapeutic management
por: Shaik Mohamed Sayed, Ummul Fathima, et al.
Publicado: (2023) -
In vitro Dissolution Profile at Different Biological pH Conditions of Hydroxychloroquine Sulfate Tablets Is Available for the Treatment of COVID-19
por: Dongala, Thirupathi, et al.
Publicado: (2021) -
Therapeutic implications of current Janus kinase inhibitors as anti-COVID agents: A review
por: Jain, Nem Kumar, et al.
Publicado: (2023)